Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland

Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland

BACKGROUND The introduction of direct acting antivirals (DAAs) for the therapy of chronic hepatitis C (CHC) has revolutionised treatment and marks a paradigm shift in the approach to this disease, rendering interferon-based therapies obsolete. AIMS OF THE STU...

Full description

Bibliographic Details
Main Authors: Jacqueline A. Bachofner, Piero V. Valli, Irina Bergamin, Arne Kröger, Patrizia Künzler, Adriana Baserga, Dominique L. Braun, Burkhardt Seifert, Anja Moncsek, Jan Fehr, David Semela, Lorenzo Magenta, Beat Müllhaupt, Benedetta Terziroli Beretta-Piccoli, Joachim C. Mertens, the Swiss Hepatitis C Cohort Study
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2018-01-01
Series:Swiss Medical Weekly
Subjects:
chronic hepatitis C
Online Access:https://www.smw.ch/index.php/smw/article/view/2434

Internet

https://www.smw.ch/index.php/smw/article/view/2434

Similar Items